Atlas Trials

Evaluation of Efficacy and Safety of the Concomitant of RUTI® Immunotherapy With the Standard Treatment in TB Patients

Clinical trial NCT05136833 · WITHDRAWN

Trial details

NCT number
NCT05136833
Sponsor
Archivel Farma S.L.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculosis
Start date
2021-12-01
Primary completion
2022-06-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.